Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Pedro Asensi Cantó

Has grant

Médico Adjunto

Hospital Universitari i Politècnic La Fe

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Recent Grants

Grant: Open

Medicina de precisión en la enfermedad injerto contra receptor: biomarcadores, prevención y tratamiento personalizado tras el trasplante alogénico

Open Date: 2027-01-01

Close Date: 2030-12-01

Grant: Close

Terapia celular e inmunoterapia en el tratamiento de neoplasias hematológicas.

Open Date: 2024-01-01

Close Date: 2025-12-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Luisa Sisinni

Fundación para la Investigación Biomédica del Hospital Universitario La Paz

SPAIN

View details

Marta Moreno Torres

Ramón y Cajal Researcher

University of Valencia

SPAIN

View details

Javier de la Rubia

Head of Department

Hospital Universitari i Politècnic La Fe

SPAIN

View details

Miguel Sanz

Full Professor - Honorary Professor

University of Valencia

SPAIN

View details

Jaime Sanz

Profesor Titular de Universidad

University of Valencia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pedro Asensi Cantó

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation

Mutational Landscape and Clonal Dynamics in AML Undergoing PTCy Hematopoietic Cell Transplantation

Redefining Engraftment Syndrome After Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantation: A Novel Classification and Impact on Outcomes

Secondary Malignancies After Hematopoietic Stem Cell Transplantation

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation

Spanish Real-World Experience with Belumosudil for Chronic Graft-versus-Host Disease after 2 or More Prior Lines of Therapy

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure

Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide

Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide

Patient Blood Management in Hematology: Focusing on Platelet Transfusion

Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole Prophylaxis

Absence of Red Blood Cell Alloimmunization in Transfused Patients Receiving Daratumumab: Experience from a Single Center

Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy

Gastric Bleeding in Stem Cell Transplantation: A Focus on Gastric Vascular Ectasia Under Post-Transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil Prophylaxis

Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience

Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide

Interference of Monoclonal Antibody Therapy in Transfusion: An Update

Inmunoterapia en el mieloma múltiple

Collaborators (5)

Luisa Sisinni

Marta Moreno Torres

Javier de la Rubia

Miguel Sanz

Jaime Sanz

Make your next move.